19 July 2017 - The issue of expensive cancer therapies is taken up by the American Society of Clinical Oncology (ASCO) in a new position statement that offers several possible solutions to make drugs more affordable.

"We need our nation's leaders to tackle the major drivers of patients' cost burdens, including rising prices," said ASCO Chief Executive Officer Clifford A. Hudis, MD.

"In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," he added.

Read Medscape article